Considering that EMT-activating transcription factors (EMT-TFs) are linked to chemoresistance [40], we showed that chemoresistance to anti-cancer drugs such as cisplatin, 5-FU, and doxorubicin, might be attributed to the loss of PGC1α-induced EMT. This evidence concerns the gene PPARGC1A and cancer.